HK60894A - Pharmaceutical compositions containing furan derivatives - Google Patents

Pharmaceutical compositions containing furan derivatives Download PDF

Info

Publication number
HK60894A
HK60894A HK60894A HK60894A HK60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
furan derivatives
containing furan
salt
Prior art date
Application number
HK60894A
Other languages
English (en)
Inventor
Richard Smith Norman
Roy Heppenstall Colin
John Douglas Stephen
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HK60894A publication Critical patent/HK60894A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
HK60894A 1990-09-11 1994-06-23 Pharmaceutical compositions containing furan derivatives HK60894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (1)

Publication Number Publication Date
HK60894A true HK60894A (en) 1994-07-08

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
HK60894A HK60894A (en) 1990-09-11 1994-06-23 Pharmaceutical compositions containing furan derivatives

Country Status (33)

Country Link
US (1) US5456925A (de)
EP (1) EP0558779B1 (de)
JP (1) JPH0692849A (de)
KR (1) KR100196308B1 (de)
AT (2) AT405134B (de)
AU (2) AU640816B2 (de)
BE (1) BE1005115A5 (de)
BG (1) BG61931B1 (de)
CA (1) CA2050970C (de)
CH (1) CH683068A5 (de)
CY (1) CY1988A (de)
DE (2) DE4130061A1 (de)
DK (1) DK159191A (de)
ES (1) ES2072647T3 (de)
FI (1) FI944047A0 (de)
FR (1) FR2666508B1 (de)
GB (2) GB9019875D0 (de)
HK (1) HK60894A (de)
HU (1) HU211846A9 (de)
IE (1) IE65049B1 (de)
IL (1) IL99428A (de)
IT (1) IT1249696B (de)
MX (1) MX9101009A (de)
NL (1) NL194907C (de)
NO (1) NO179694C (de)
NZ (1) NZ239731A (de)
OA (1) OA10093A (de)
RO (1) RO112084B1 (de)
RU (1) RU2108097C1 (de)
SE (1) SE509694C2 (de)
SK (1) SK279591B6 (de)
WO (1) WO1993017679A1 (de)
ZA (1) ZA917176B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
RU2385155C2 (ru) * 1998-08-18 2010-03-27 Федеральное Государственное Унитарное Предприятие Государственный Научно-Исследовательский Институт "Биоэффект" (Фгуп Гнии "Биоэффект") Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения
EP1104673A1 (de) * 1999-11-30 2001-06-06 Bayer Classics Ein Hydrogencarbonat enthaltendes sprengmittelfreies Arzneimittel
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2021244481A1 (en) * 2020-06-01 2021-12-09 The University Of Hong Kong Compositions and methods for treating a sars-cov-2 infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
RU2108097C1 (ru) 1998-04-10
BG99021A (bg) 1995-06-30
FI944047A7 (fi) 1994-09-02
KR920005984A (ko) 1992-04-27
AU8375791A (en) 1992-03-19
ZA917176B (en) 1992-06-24
FR2666508A1 (fr) 1992-03-13
MX9101009A (es) 1992-05-04
GB2248185A (en) 1992-04-01
IL99428A0 (en) 1992-08-18
OA10093A (en) 1996-12-18
GB9119284D0 (en) 1991-10-23
DE4130061A1 (de) 1992-03-12
GB2248185B (en) 1994-02-02
IE65049B1 (en) 1995-10-04
IL99428A (en) 1996-06-18
AT405134B (de) 1999-05-25
FR2666508B1 (fr) 1994-02-18
WO1993017679A1 (en) 1993-09-16
FI944047L (fi) 1994-09-02
HU211846A9 (en) 1995-12-28
SK279591B6 (sk) 1999-01-11
DE69202696D1 (de) 1995-06-29
ATA180191A (de) 1998-10-15
NO920408D0 (no) 1992-01-30
IE913191A1 (en) 1992-04-22
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
NO179694C (no) 1996-12-04
EP0558779A1 (de) 1993-09-08
CA2050970A1 (en) 1992-03-12
US5456925A (en) 1995-10-10
ITRM910673A1 (it) 1993-03-10
CA2050970C (en) 2002-11-19
NO179694B (no) 1996-08-26
AU1334792A (en) 1993-10-05
ATE122883T1 (de) 1995-06-15
NL9101533A (nl) 1992-04-01
DK159191D0 (da) 1991-09-10
DK159191A (da) 1992-03-12
EP0558779B1 (de) 1995-05-24
BE1005115A5 (fr) 1993-04-27
NO920408L (no) 1993-08-02
CY1988A (en) 1997-09-05
CH683068A5 (fr) 1994-01-14
GB9019875D0 (en) 1990-10-24
JPH0692849A (ja) 1994-04-05
IT1249696B (it) 1995-03-09
FI944047A0 (fi) 1994-09-02
ITRM910673A0 (it) 1991-09-10
KR100196308B1 (ko) 1999-06-15
SE9102604D0 (sv) 1991-09-10
SK106094A3 (en) 1995-02-08
BG61931B1 (bg) 1998-10-30
NZ239731A (en) 1993-10-26
NL194907C (nl) 2003-07-04
RO112084B1 (ro) 1997-05-30
ES2072647T3 (es) 1995-07-16
AU640816B2 (en) 1993-09-02
SE509694C2 (sv) 1999-02-22

Similar Documents

Publication Publication Date Title
HK60894A (en) Pharmaceutical compositions containing furan derivatives
TW427914B (en) Mycophenolate mofetil high dose oral suspensions
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
IL103688A0 (en) Substituted biphenylpyridones,their preparation and pharmaceutical compositions containing them
AU587622B2 (en) Isoxazole and furan derivatives, their preparation and use as antiviral agents
IE782130L (en) Imidazolidinones
MX18786A (es) Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo.
IE873125L (en) Benzimidazole derivatives
IE871730L (en) Calcium compositions
HK19095A (en) Pharmaceutical compositions containing ranitidine
AU6927787A (en) Insecticidally active, fluorinated phenylalkane and phenylalkene derivatives
GB2021409A (en) Pharmaceutical composition
AU7680187A (en) Epoxy oligosaccharides
IE790954L (en) Pharmaceutical formulations containing prostaglandin¹compounds
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
IL83411A0 (en) Benzohydroxamic acid derivatives,their preparation and their use as herbicides
AU4591589A (en) Doxorubicin aqueous solutions
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
DK163661C (da) 2,5-pyrrolidindionderivater og farmaceutisk acceptable syreadditionssalte deraf
IT7830125A0 (it) Associazione di antibiotici caratterizzata da diminuita tossicita', e composizioni farmaceutiche relative.
CA2172506A1 (en) Mycophenolate mofetil and mycophenolic acid high dose oral suspensions
JPS5283517A (en) Novel derivatives of antibiotics xk-62-2

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060910